Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04041219 · ClinicalTrials.gov registry record · Phase 4
Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT04041219: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT04041219 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04041219, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
Researchers are trying to learn more about using sublingual (absorption under the tongue) tacrolimus in blood and marrow transplant patients.
Interventions
- DRUG Tacrolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-06-17 |
| Est. Completion | 2019-10-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04041219
The ClinicalTrials.gov registry entry for NCT04041219 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tacrolimus is the first listed.
NCT04041219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04041219 about?
NCT04041219 is a clinical study titled "Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients". Researchers are trying to learn more about using sublingual (absorption under the tongue) tacrolimus in blood and marrow transplant patients.
What is the current status of trial NCT04041219?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2019-06-17. Estimated completion is 2019-10-08.
What interventions are being tested in trial NCT04041219?
The interventions under investigation include: Tacrolimus (DRUG).
Who is sponsoring clinical trial NCT04041219?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.